Aptamer Sciences Inc

KOSDAQ:A291650 Voorraadrapport

Marktkapitalisatie: ₩31.6b

Aptamer Sciences Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Dongil Han

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO16.5%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Health Check: How Prudently Does Aptamer Sciences (KOSDAQ:291650) Use Debt?

Jul 26
Health Check: How Prudently Does Aptamer Sciences (KOSDAQ:291650) Use Debt?

Is Aptamer Sciences (KOSDAQ:291650) A Risky Investment?

Mar 26
Is Aptamer Sciences (KOSDAQ:291650) A Risky Investment?

CEO

Dongil Han

no data

Tenure

Dongil Han serves as Chief Executive Officer and Chairman of Aptamer Sciences Inc. Dongil Han was an Executive at POSTECH biotechnology and SK Biopharmaceuticals. Dongil Han was a Team leader in drug devel...